Regulation of plasma fatty acid metabolism

Clinica Chimica Acta

Volumn 286, Issue 1-2, 1999, Pages 163-180

  Saleh, Jumana ^a   Sniderman, Allan D ^a   Cianflone, Katherine ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANGIOTENSIN; CATECHOLAMINE DERIVATIVE; ESTROGEN; FATTY ACID; FATTY ACID BINDING PROTEIN; FATTY ACID SYNTHASE; GROWTH HORMONE; INSULIN; LEPTIN; NEUROPEPTIDE; PROGESTERONE; SEX HORMONE; TESTOSTERONE; TRIACYLGLYCEROL; VANADIC ACID;

ADIPOSE TISSUE; CONFERENCE PAPER; ESTERIFICATION; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; FATTY ACID TRANSPORT; HUMAN; LIPOGENESIS; LIPOLYSIS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; REGULATORY MECHANISM;

BODY CONSTITUTION; CATECHOLAMINES; FATTY ACIDS; FEEDBACK; FEMALE; HUMANS; INSULIN; LIPOLYSIS; MALE; OBESITY; SEX FACTORS;

EID: 0032865063     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00099-6     Document Type: Conference Paper

References (105)

1. Bjorntorp P., Bradoff B.N. Obesity. 1992;3-12 Lippincott J B Company, Philadelphia Penn.
2. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease. Obes Res. 4:1996;204-212.
3. Vague J. La différenciation sexuelle, facteur determinant des formes de l'obésité Presse Méd. 30:1947;339.
4. Wing R.R., Bunker C.H., Kuller L.H., Mathews K.A. Insulin, body mass index and cardiovascular risk factors in premenopausal women. Arteriosclerosis. 9:1989;479-484.
5. Peiris A.N., Struve M.F., Kissebah A.H. Relationship of body fat distribution to the metabolic clearance of insulin in premenopausal women. Intl J Obesity. 11:1987;581-589.
6. Karjalainen L., Pihlajamaki J., Karhapaa P., Laakso M. Impaired insulin-stimulated glucose oxidation and free fatty acid suppression in patients with familial combined hyperlipidemia: a precursor defect for dyslipidemia? Arterioscler Thromb Vasc Biol. 18:1998;1548-1553.
7. Despres J.P. The insulin resistance-dyslipidemia syndrome: the most prevalent cause of coronary artery disease? Can Med Assoc J. 148:1993;1339-1340.
8. Despres J.P., Moorjani S., Lupien P.J., Tremblay A., Nadeau A., Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis. 10:1990;497-511.
9. Bjorntorp P. Portal adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis. 10:1990;493-496.
10. Bjorntorp P. How should obesity be defined? J Intern Med. 227:1990;147-149.
11. Jensen M.D., Haymond M.W., Rizza R.A., Cryer P.E., Miles P.E. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest. 83:1989;1168-1173.
12. Despres J.P. The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk. Obes Res. 6:1998;85-175.
13. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes. 46:1997;3-10.
14. Bengtsson G., Olivecrona T. Lipoprotein lipase. Mechanism of product inhibition. Eur J Biochem. 106:1980;557-562.
15. Posner I., DeSanctis J. Kinetics of product inhibition and mechanisms of lipoprotein lipase activation by apolipoprotein C-II. Biochemistry. 26:1987;3711-3717.
16. Saxena U., Witte L.D., Goldberg I.J. Release of endothelial lipoprotein lipase by plasma lipoproteins and free fatty acids. J Biol Chem. 264:1989;4349-4355.
17. Sniderman A.D., Cianflone K. Substrate delivery as a determinant of hepatic apoB secretion. Arterioscler Thromb. 13:1993;629-636.
18. Lewis G.F. Fatty acid regulation of very low density lipoprotein production. Curr Opin Lipidology. 8:1997;146-153.
19. Sessler A.M., Ntambi J.M. Polyunsaturated fatty acid regulation of gene expression. J Nutr. 128:1998;923-926.
20. Niot I., Poirier H., Besnard P. Regulation of gene expression by fatty acids: special reference to fatty acid-binding protein (FABP). Biochimie. 79:1997;129-133.
21. Cheema S.K., Clandinin M.T. Diet fat alters expression of genes for enzymes of lipogenesis in lean and obese mice. Biochim Biophys Acta. 1299:1996;284-288.
22. Bastard J.P., Bruckert E., Robert J.J. Are free fatty acids related to plasma plasminogen activator inhibitor I in android obesity? Int J Obes Relat Metab Disord. 19:1995;836-838.
23. McGarry J.D. Glucose-fatty acid interactions in health and disease. Am J Clin Nutri. 67:1998;5500-5504.
24. Colberg S.R., Simoneau J.A., Thaete F.L., Keeley D.E. Skeletal muscle utilization of free fatty acids in women with visceral obesity. J Clin Invest. 95:1995;1846-1853.
25. Van Baak M.A., Schiffelers S.L.H., Saris W.H.M. Increased NEFA availability leads to a similar increase in energy expenditure and fat oxidation in lean and obese men. Int J Obes. 22:1998;S157.
26. Vettor R., Lombardi A.M., Fabris R. FFA. infusion induces insulin resistance and increases ob gene expression and leptin plasma levels in rats. Int J Obes. 22:1998;S168.
27. Shimabukuro M., Zhou Y.T., Levi M., Unger R.H. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Nat Acad Sci USA. 95:1998;2498-2502.
28. Lu G., Morinelli T.A., Meier K.E., Rosenzweig S.A., Egan B.M. Oleic acid-induced mitogenic signaling in vascular smooth muscle cells. A role for protein kinase C. Circ Res. 79:1996;611-618.
29. Morisaki N., Lindsey J.A., Milo G.E., Cornwell D.G. Fatty acid metabolism and cell proliferation. III. Effect of prostaglandin biosynthesis either from exogenous fatty acid or endogenous fatty acid release with hydralazine. Lipids. 18:1983;349-352.
30. Khan W.A., Blobe G.C., Hannun Y.A. Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C. Cell Signal. 7:1995;171-184.
31. Lee Y.M., Birgel M., Hube F., Hauner H. Free fatty acids are potent stimulators of differentiation in human preadipocytes. Int J Obes. 22:1998;514.
32. Van Epps-Fung M., Williford J., Wells A., Hardy R.W. Fatty acid-induced insulin resistance in adipocytes. Endocrinology. 138:1997;4338-4345.
33. Fickova M., Hubert P., Cremel G., Leray C. Dietary (n-3) and (n-6) polyunsaturated fatty acids rapidly modify fatty acid composition and insulin effects in rat adipocytes. J Nutrition. 128:1998;512-519.
34. Komers R., Vrana A. Thiazolidinediones - tools for the research of metabolic syndrome X. Physiol Res. 47:1998;215-225.
35. Schoonjans K., Martin G., Staels B., Auwerx J. Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr Opin Lipidology. 8:1997;159-166.
36. Negrel R. Paracrine/autocrine signals and adipogenesis. Int J Obes. 22:1998;520.
37. Muller G., Wied S., Piossek C., Bauer A., Bauer J., Frick W. Convergence and divergence of the signaling pathways for insulin and phosphoinositolglycans. Mol Med. 4:1998;299-323.
38. Safonova I., Aubert J., Negrel R., Ailhaud G. Regulation by fatty acids of angiotensinogen gene expression in preadipose cells. Biochem J. 322:1997;235-239.
39. Bergene E., Ukropec J., Liska B., et al. n-3 Fatty acids decrease plasma leptin levels in dietary induced hypertriglyceridemia and insulin resistance. Int J Obes. 22:1998;5221.
40. Maslowska M., Scantlebury T., Germinario R., Cianflone K. Acute in vitro production of ASP in differentiated adipocytes. J Lipid Res. 38:1997;21-31.
41. Scantlebury T., Maslowska M., Cianflone K. Chylomicron specific enhancement of Acylation Stimulating Protein (ASP) and precursor protein C3 production in differentiated human adipocytes. J Biol Chem. 273:1998;22903-22909.
42. Saleh J., Summers L.K.M., Cianflone K., Fielding B.A., Sniderman A.D., Frayn K.N. Coordinated release of acylation stimulating protein (ASP) and triacyglycerol clearance by human adipose tissue in vivo in the postprandial period. J Lipid Res. 39:1998;884-891.
43. Amer P. Obesity and the adipocyte: regional adipocity in man. J Endo. 155:1997;191-192.
44. Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann Med. 27:1995;435-438.
45. Bjorntorp P. The regulation of adipose tissue distribution in humans. Int J Obes. 20:1996;291-302.
46. Bjorntorp P. Hormonal control of regional fat distribution. Hum Reprod. 12:1997;21-25.
47. Reynisdottir S., Dauzats M., Thorne A., Langin D. Comparison of hormone-sensitive lipase activity in visceral and subcutaneous human adipose tissue. J Clin Edocrinol Metab. 82:1997;4162-4166.
48. Olivecrona G., Olivecrona T. Triglyceride lipases and atherosclerosis. Curr Opin Lipidology. 6:1995;291-305.
49. Brun L.D., Gagne C., Julien P. Familial lipoprotein lipase activity deficiency: study of total body fatness and subcutaneous fat tissue distribution. Metabolism. 38:1989;1005-1009.
50. Abumrad N.A., el-Maghrabi M.R., Amri E.Z., Lopez E., Grimaldi P.A. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem. 268:1993;17665-17668.
51. Caserta F., Civelek V., Hamilton J.A., Kirkland J.L., Corkey B.E. Differences in free fatty acid uptake in differentiated preadipocytes from different anatomic regions. Int J Obes. 22:1998;557.
52. Scheja L., Makowski L., Shimshek D.R. Impaired lipolysis and altered insulin secretion in mice deficient for the adipocyte fatty acid-binding protein, aP2. Int J Obes. 22:1998;532.
53. Walldius G. What happens after lipoprotein lipase? A low fatty acid incorporation into adipose tissue (FIAT) in hypertriglyceridaemia-experimental and clinical studies. Int J Obes. 5:1981;707-716.
54. Walldius G. Serum triglycerides and fatty acid incorporation into human adipose tissue (FIAT). Their relations with adipose tissue characteristics and glucose tolerance. Acta Medica Scand. 200:1976;409-421.
55. Edens N.K., Fried S.K., Kral J.G., Hirsch J., Leibel R.L. In vitro lipid synthesis in human adipose tissue from three abdominal sites. Am J Physiol. 265:1993;E374-E379.
56. Ostman J., Amer P., Engfeldt P., Kager L. Regional differences in the control of lipolysis in human adipose tissue. Metabolism. 28:1979;1198-1205.
57. Maslowska M., Sniderman A.D., MacLean L.D., Cianflone K. Regional differences in triacylglycerol synthesis in adipose tissue. J Lipid Res. 34:1993;219-228.
58. Giudicelli Y. Expression and possible role of sex steroid receptors in rat and human preadipocytes during adipogenesis. Int J Obes. 22:1998;529.
59. Sutter-Dub M.T., Cordoba P. Acute effects of progesterone on glucose metabolism in rat adipocytes: are they modulated by endogenous adenosine? Metab Clin Exp. 46:1997;595-604.
60. Goto T., Hinata T., Suda T. Gender difference in antilipolytic action of insulin in relation to body fat distributions. Int J Obes. 22:1998;517.
61. 2-adrenoceptor mediated lipolysis and fat oxidation are reduced in obese men. Int J Obes. 22:1998;575.
62. Guo Z., Johnson C.M., Jensen M.D. Regional lipolytic responses to isoproterenol in women. Am J Physiol. 273:1997;E108-E112.
63. Van Harmelen V., Lonnqvist F., Thorne A. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects. Int J Obes Relat Metab Disord. 21:1997;972-979.
64. Kolehmainen M., Ohisalo J.J., Paakkonen M., Poikolainen E., Alhava E., Uusitupa M.I.J. Weakened inhibition of adipose tissue lipolysis is related to disturbed glucose metabolism in severe obesity. Int J Obes. 22:1998;5108.
65. Lonnqvist F., Thorne A., Large V., Amer P. Sex differences in visceral fat lipolysis and metabolic complications of obesity. Arterioscler Thromb Vasc Biol. 17:1997;1472-1480.
66. Jones J.P., Dohm G.L. Regulation of glucose transporter GLUT-4 and hexokinase II gene transcription by insulin and epinephrine. Am J Physiol (Endocrinol Metab). 273:1997;E682-E687.
67. Stevenson R.W., Kreutter D.K., Andrews K.M., Genereux P.E., Gibbs E.M. Possibility of distinct insulin-signaling pathways beyond phosphatidylinositol 3-kinase-mediating glucose transport and lipogenesis. Diabetes. 47:1998;179-185.
68. Fried S.K., Russell C.D., Papaspyrou-Rao S., Ricci M.R., Bunkin D.A. Regional differences in the hormonal regulation of lipoprotein lipase and leptin expression in human omental and subcutaneous adipose tissue. Int J Obes. 22:1998;520.
69. Arner P., Bolinder J., Engfeldt P., Ostman J. The antilipolytic effect of insulin in human adipose tissue in obesity, diabetes mellitus, hyperinsulinemia and starvation. Metabolism. 30:1981;753-760.
70. Sinha M.K., Taylor L.G., Pories W.J. Long-term effect of insulin on glucose transport and insulin binding in cultured adipocytes from normal and obese humans with and without non-insulin-dependent diabetes. J Clin Invest. 80:1987;1073-1081.
71. Skarda J. Effect of bovine growth hormone on growth, organ weights, tissue composition and adipose tissue metabolism in young castrated male goats. Livestock Prod Sci. 55:1998;215-225.
72. Castan I., Wijkander J., Manganiello V., Belfrage P., Degerman E. Mechanisms of inhibition of lipolysis by insulin, vanadate and peroxovanadate in rat adipocytes. Int J Obes. 22:1998;S109.
73. Aguado M., Fruhbeck G., Margareto J., Martinez J.A. Neuropeptide Y decreases basal lipolytic activity on isolated adipocytes from wistar rats. Int J Obes. 22:1998;S109.
74. Souza S.C., Yamamoto M.T., Franciosa M.D., Lien P., Greenberg A.S. BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazol idinediones. Diabetes. 47:1998;691-695.
75. Gaudiot N., Jaubert A.M., Lacasa D., Sabourault D., Giudicelli Y., Ribiere C. Modulation of white adipose tissue lipolysis by nitric oxide (NO): role of the NO redox state. Int J Obes. 22:1998;S101.
76. Lacasa D., Giudicelli Y., Ribiere C. Modulation of white adipose tissue lipolysis by nitric oxide. J Biol Chem. 273:1998;13475-13481.
77. Fruhbeck G., Aguado M., Martinez J.A. In vitro lipolytic effect of leptin on mouse adipocytes: evidence for a possible autocrine/paracrine role of leptin. Biochem Biophys Res Commun. 240:1997;590-594.
78. Fruhbeck G., Aguado M., Gomez-Ambrosi J., Martinez J.A. Lipolytic effect of in vivo leptin administration on adipocytes of lean and ob/ob mice, but not db/db mice. Biochem Biophys Rese Commun. 250:1998;99-102.
79. Fruhbeck G., Aguado M., Gomez-Ambrosi J., Martinez J.A. In vivo leptin administration increases basal adipocyte lipolysis of ob/ob mice, but not db/db mice. Int J Obes. 22:1998;S176.
80. Wilkison W.O., Moustaid-Moussa N., Mynatt R.L. Role of adipocyte and pancreas intracellular calcium in agouti-induced obesity. Int J Obes. 22:1998;557.
81. LeBlanc J., Picard F., Huang Q., Lalonde J., Richard D., Deshaies Y. DHEA and its metabolite etiocholanedione acutely increase adipose tissue lipoprotein lipase in mice. Int J Obes. 22:1998;5189.
82. Yip R.G.C., Boylan M.O., Wolfe M.M. Glucose-dependent insulinotropic polypeptide receptors are present and functional on fat cells. Int J Obes. 22:(3):1998;530.
83. Montrose-Rafizadeh C., Yang H., Wang Y., Roth J., Montrose M.H., Adams L.G. Novel signal transduction and peptide specificity of glucagon-like peptide receptor in 3T3-L1 adipocytes. J Cell Physiol. 172:1997;275-283.
84. Bai Y., Zhang S., Kim K.S., Lee J.K., Kim K.H. Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones. J Biol Chem. 271:1996;13939-13942.
85. Prins J.B., Niesler C.U., Winterford C.M. Tumor necrosis factor-alpha induces apoptosis of human adipose cells. Diabetes. 46:1997;1939-1944.
86. Marette A., Perreault M., Bédard S., Roy D., Kapur S. Nitric oxide: a new player in skeletal muscle and adipose tissue metabolism. Int J Obes. 22:1998;S101.
87. Jones B.H., Standridge M.K., Moustaid N. Angiotensin II increases lipogenesis in 3T3-LI and human adipose cells. Endocrinology. 138:1997;1512-1519.
88. Moustaid-Moussa N., Standridge M., Jones B.H. Differential effects of angiotensin II receptor blockade in lean and obese mice. Int J Obes. 22:1998;574.
89. Claycombe K.J., Moustaid-Moussa N., Xue B., Zemel M.B., Mynatt R., Wilkison W.O. Mechanisms of agouti-induced obesity: effects on adipocyte metabolism. Int J Obes. 22:1998;S102.
90. Cianflone K., Roncari D.A.K., Maslowska M., Baldo A., Forden J., Sniderman A.D. The adipsin-acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry. 33:1994;9489-9495.
91. Choy L.N., Rosen B.S., Spiegelman B.M. Adipsin and an endogenous pathway of complement from adipose cells. J Biol Chem. 267:1992;12736-12741.
92. Cianflone K., Maslowska M. Differentiation induced production of ASP in human adipocytes. Eur J Clin Invest. 25:1995;817-825.
93. Cianflone K. The acylation stimulating protein pathway: clinical implications. Clin Biochem. 30:1997;301-312.
94. Cianflone K., Sniderman A.D., Kalant D., Marliss E.B., Gougeon R. Response of plasma ASP to a prolonged fast. Intl J Obesity. 19:1995;604-609.
95. Walsh M.J., Sniderman A.D., Cianflone K., Vu H., Rodriguez M.A., Forse R.A. The effect of ASP on the adipocyte of the morbidly obese. J Surg Res. 46:1989;470-473.
96. Kissebah A.H., Vydelingum N., Murray R. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab. 54:1982;254-260.
97. Ciaraldi T.P., Kolterman O.B., Olefsky J.M. Mechanism of the postreceptor defect in insulin action in human obesity. Decrease in glucose transport system activity. J Clin Invest. 68:1981;875-880.
98. Murray I., Sniderman A., Phelis S., Wetsel R., Colten H., Cianflone K. Postprandial triglyceride metabolism in a functional acylation stimulating (ASP) knockout mouse. Int J Obesity. 22:1998;533.
99. Saleh J., Sniderman A., Cianflone K. Postprandial triacylglycerol clearance in ob/ob and db/db mice: physiological effects of ASP in mice models of obesity and hypertriglyceridemia. Int J Obesity. 22:1998;S183.
100. Heffernan M., Ogru E., Igniatovic V., Gianello R., Jiang W.J., Ng F. Sensitivity of human subcutaneous adipose tissues to the lipolytic action of an anti-obesity compound A0D9401. Int J Obesity. 22:1998;S110.
101. Motoyashiki T., Miyake M., Morita M., Mizutani K., Ueki H. Enhancement of the vanadate-stimulated release of lipoprotein lipase activity by astilbin from the leaves of Engelhardtia chrysolepis. Biol Pharm Bull. 21:1998;517-519.
102. Ottoson M., Oden B., Eden S. The effects of BRL49653, an insulin-sensitizing agent, on lipoprotein lipase activity in human adipose tissue. Int J Obes. 22:1998;570.
103. Iwao N., Oshida Y., Sato Y. Regional difference in ipolysis caused by a beta-adrenergic agonist as determined by the microdialysis technique. Acta Physiol Scand. 161:1997;481-487.
104. Labelle M., Boulanger Y., Fournier A., St.Pierre S., Savard R. Tissue-specific regulation of fat cell lipolysis by NPY in 6-OHDA-treated rats. Peptides. 18:1997;801-808.
105. Girouard H., Savard R. The lack of bimodality in the effects of endogenous and exogenous prostaglandins on fat cell lipolysis in rats. Prostaglandis and Other Lipid Mediators. 56:1998;43-52.